Search

everythinglearnresearchcommunity

for

Search:↓

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

AH-001 could be a safer and more effective treatment for hair loss.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Some dibenzo compounds might help treat cancer with fewer side effects.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

A new treatment for hair loss shows promise with fewer side effects.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

New compounds may help treat prostate issues without affecting androgen receptors.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Potassium channel openers help form elastic fibers in arteries and can treat elastin deficiency and hypertension.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Analog 23 is a promising compound for prostate cancer treatment.

Targeting the MC-5-HT-HTR2A axis may help treat chronic itching.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Extracellular ATP promotes growth, while adenosine inhibits it in Arabidopsis plants.